| London Stock Exchange: PURI
PuriCore Plc is a water-based clean technology company, which focuses on developing and commercializing proprietary solutions that protect people from the spread of infectious pathogens. The company's antimicrobial technology and complementary products are used in two core businesses: retail supermarkets in the U.S and Canada, and the endoscope decontamination. In addition, it focuses on partnership opportunities in health sciences segments, including wound care, dermatology, dental, and animal health, as well as in new food & agriculture market segments, including agriculture and water treatment. The company operates through three segments: Endoscopy, Supermarket Retail and Wound Care. The Endoscopy segment offers full range of surgical, scientific and endoscopy consumable products. The Supermarket Retail segment's Sterilox Fresh solution aims to improve shelf life and home life for fresh produce, and FloraFresh Solution improves the quality of final products. The Wound Care segment offers dental and wound care solutions. This segment's Vashe Wound Therapy is used in debriding, lubricating, and moistening chronic and acute wounds. PuriCore was founded on April 21, 2006 and is headquartered Malvern, PA.